Peptides
GLP-1's Expanding Frontier: Type 1 Modeling and the Brown-Fat PET Surprise
GLP-1 receptor agonists keep pushing into new clinical territory. Two 2025 papers — a modeling review for type 1 diabetes and a case report where semaglutide lit up brown fat on a PET scan — hint at what's next.